Funding Round attributes
Phantom Neuro, a neurotechnology company based in Austin, Texas, has secured $19 million in a Series A funding round. The investment was led by Ottobock, a global leader in prosthetics and orthotics, and included participation from existing investors Breakout Ventures, Draper Associates, LionBird Ventures, Time BioVentures, and Risk and Return. New investors in this round comprised Actual VC, METIS Innovative, e1 Ventures, Jumpspace, MainSheet Ventures, and Brown Advisory.
The funds are earmarked for several key initiatives: advancing preclinical testing, completing first-in-human trials, pursuing regulatory submissions, and expanding research and development efforts to extend the company's technology beyond prosthetic limbs.
Phantom Neuro is developing a minimally invasive interface designed to enable intuitive control of prosthetic limbs and robotic exoskeletons. The company's core platform, Phantom X, aims to restore natural movement and functionality for amputees and individuals with mobility impairments, allowing robotic devices to function as seamless extensions of the human body.
With this latest funding round, Phantom Neuro's total funding has reached $28 million.
